REFERENCES
- SP Baldwin, and WM Saltzman. (1998). Materials for protein delivery in tissue engineering. Adv. Drug Delivery Rev. 33:71–86.
- SD Putney. (1998). Encapsulation of proteins for improved delivery. Curr. Opin. Biol. Chem. 2:548–552.
- Y Tabata. (2005). Significance of release technology in tissue engineering. Drug Discov. Today. 10:1639–1646.
- D Kaigler, JA Cirelli, and WV Giannobile. (2006). Growth factor delivery for oral and periodontal tissue engineering. Expert Opin. Drug Deliv. 3:647–662.
- Y Suzuki, Y Nishimura, M Tanihara, K Suzuki, T Nakamura, Y Shimizu, Y Yamawaki, and Y Kakimaru. (1998). Evaluation of a novel alginate gel dressing: cytotoxicity to fibroblasts in vitro and foreign-body reaction in pig skin in vivo. J. Biomed. Mater. Res. 39:317–322.
- M Tanihara, Y Suzuki, E Yamamoto, A Noguchi, and Y Mizushima. (2001). Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J. Biomed. Mater. Res. 56:216–221.
- K Kawai, S Suzuki, Y Tabata, Y Ikada, and Y Nishimura. (2000). Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials. 21:489–499.
- M Yamamoto, Y Tabata, H Kawasaki, and Y Ikada. (2000). Promotion of fibrovascular tissue ingrowth into porous sponges by basic fibroblast growth factor. J. Mater. Sci. Mater. Med. 11:213–218.
- M Yamamoto, Y Takahashi, and Y Tabata. (2003). Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials. 24:4375–4383.
- A Venien, and D Levieux. (2005). Differentiation of bovine from porcine gelatines using polyclonal anti-peptide antibodies in indirect and competitive indirect ELISA. J. Pharm. Biomed. Anal. 39:418–424.
- NJ Meilander, X Yu, NP Ziats, and RV Bellamkonda. (2001). Lipid-based microtubular drug delivery vehicles. J. Control. Release. 71:141–152.
- U Gietza, T Arvinteb, E Maderc, P Oroszlanc, and HP Merkle. (1998). Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model. Eur. J. Pharm. Biopharm. 45:259–264.
- A Esquisabel, RM Rernandes, M Igartua, AR Gascon, B Calvo, and JL Pedraz. (2002). Preparation and stability of agarose microcapsules containing BCG. J. Microencapsul. 19:237–244.
- N Wan, and XS Wu. (1997). Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery. Pharm. Dev. Technol. 2:135–142.
- SP Sanghvi, and JG Nairn. (1992). Effect of viscosity and interfacial tension on particle size of cellulose acetate trimellitate microspheres. J. Microencapsul. 9:215–227.
- C Thomasin, HP Merkle, and B Gander. (1998). Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. J. Pharm. Sci. 87:269–275.
- Y Tabata, and Y Ikada. (1999). Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 20:2169–2175.
- O Jeon, SW Kang, HW Lim, D Choi, DI Kim, SH Lee, JH Chung, and BS Kim. (2006). Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials. 27:1617–1625.
- M Tabata, T Shimoda, K Sugihara, D Ogomi, T Serizawa, and M Akashi. (2003). Osteoconductive and hemostatic properties of apatite formed on/in agarose gel as a bone-grafting material. J. Biomed. Mater. Res. B Appl. Biomater. 67:680–688.
- MV Cabañas, J Peña, J Román, and M Vallet-Regí. (2006). Room temperature synthesis of agarose/sol-gel glass pieces with tailored interconnected porosity. J. Biomed. Mater. Res. A. 8:508–514.